WallStSmart

Futu Holdings Ltd (FUTU)vsNomura Holdings Inc ADR (NMR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nomura Holdings Inc ADR generates 9618% more annual revenue ($2.17T vs $22.31B). FUTU leads profitability with a 45.0% profit margin vs 16.7%. FUTU trades at a lower P/E of 10.8x. NMR earns a higher WallStSmart Score of 70/100 (B-).

FUTU

Strong Buy

69

out of 100

Grade: B-

Growth: 6.7Profit: 8.5Value: 6.7Quality: 5.3
Piotroski: 5/9

NMR

Strong Buy

70

out of 100

Grade: B-

Growth: 7.3Profit: 6.5Value: 7.7Quality: 3.5
Piotroski: 4/9Altman Z: 0.53

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

FUTU6 strengths · Avg: 9.2/10
P/E RatioValuation
10.8x10/10

Attractively priced relative to earnings

Profit MarginProfitability
45.0%10/10

Keeps 45 of every $100 in revenue as profit

Operating MarginProfitability
64.9%10/10

Strong operational efficiency at 64.9%

Return on EquityProfitability
24.4%9/10

Every $100 of equity generates 24 in profit

Price/BookValuation
2.5x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
28.8%8/10

Revenue surging 28.8% year-over-year

NMR4 strengths · Avg: 9.0/10
P/E RatioValuation
11.8x10/10

Attractively priced relative to earnings

Price/BookValuation
1.0x10/10

Reasonable price relative to book value

PEG RatioValuation
0.828/10

Growing faster than its price suggests

Revenue GrowthGrowth
27.5%8/10

Revenue surging 27.5% year-over-year

Areas to Watch

FUTU1 concerns · Avg: 2.0/10
EPS GrowthGrowth
-60.7%2/10

Earnings declined 60.7%

NMR4 concerns · Avg: 2.3/10
EPS GrowthGrowth
4.5%4/10

4.5% earnings growth

Free Cash FlowQuality
$-1.20T2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
0.532/10

Distress zone — elevated risk

Debt/EquityHealth
4.671/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : FUTU

The strongest argument for FUTU centers on P/E Ratio, Profit Margin, Operating Margin. Profitability is solid with margins at 45.0% and operating margin at 64.9%. Revenue growth of 28.8% demonstrates continued momentum.

Bull Case : NMR

The strongest argument for NMR centers on P/E Ratio, Price/Book, PEG Ratio. Profitability is solid with margins at 16.7% and operating margin at 18.7%. Revenue growth of 27.5% demonstrates continued momentum.

Bear Case : FUTU

The primary concerns for FUTU are EPS Growth.

Bear Case : NMR

The primary concerns for NMR are EPS Growth, Free Cash Flow, Altman Z-Score. Debt-to-equity of 4.67 is elevated, increasing financial risk.

Key Dynamics to Monitor

NMR carries more volatility with a beta of 0.61 — expect wider price swings.

FUTU is growing revenue faster at 28.8% — sustainability is the question.

Monitor CAPITAL MARKETS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NMR scores higher overall (70/100 vs 69/100), backed by strong 16.7% margins and 27.5% revenue growth. Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Futu Holdings Ltd

FINANCIAL SERVICES · CAPITAL MARKETS · China

Futu Holdings Limited operates an online brokerage and wealth management platform in Hong Kong and internationally. The company is headquartered in Hong Kong, Hong Kong.

Visit Website →

Nomura Holdings Inc ADR

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and government agencies worldwide. The company is headquartered in Tokyo, Japan.

Want to dig deeper into these stocks?